Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9Y2Y0: Variant p.Met45Arg

ADP-ribosylation factor-like protein 2-binding protein
Gene: ARL2BP
Feedback?
Variant information Variant position: help 45 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Methionine (M) to Arginine (R) at position 45 (M45R, p.Met45Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (M) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In RP82; drastic decrease ARL2-binding, diffuse cytoplasmic localization, no enrichement at cilia basal body. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 45 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 163 The length of the canonical sequence.
Location on the sequence: help VGYLEDIIMDDEFQLLQRNF M DKYYLEFEDTEENKLIYTPI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         VGYLEDIIMDDEFQLLQRNFMDKYYLEFEDTEENKLIYTPI

Mouse                         VGCLEDIIMDDEFQLLQRNFMDKYYQEFEDTEENKLTYTPI

Rat                           VGCLEDIIMDAEFQLLQRSFMDKYYQEFEDTEENKLTYTPI

Bovine                        VGYLEDIIMDDEFQLLQRNFMDKYYQEFEDTEENKLTYTPI

Chicken                       VGYLEDIIMDDDFQSIQRTFMEKHYQEFDDSEENKLIYTSI

Xenopus laevis                VGHLEDIIMDDEFQLLQHGFMDKHYHEFEDTEENKLTYTTI

Xenopus tropicalis            VGHMEDIIMDDEFQLLQHGFMDKYYHEFEDTEENKLTYTTI

Zebrafish                     IGNIEDIIMEDEFQHLQQSFMEKYYLEFDDSEENKLSYTPI
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 163 ADP-ribosylation factor-like protein 2-binding protein
Mutagenesis 56 – 56 E -> A. Decreases interaction with ARL2.
Mutagenesis 57 – 57 E -> A. Decreases interaction with ARL2.
Mutagenesis 60 – 60 L -> A. Decreases interaction with ARL2.
Helix 36 – 48



Literature citations
Mutations in ARL2BP, encoding ADP-ribosylation-factor-like 2 binding protein, cause autosomal-recessive retinitis pigmentosa.
Davidson A.E.; Schwarz N.; Zelinger L.; Stern-Schneider G.; Shoemark A.; Spitzbarth B.; Gross M.; Laxer U.; Sosna J.; Sergouniotis P.I.; Waseem N.H.; Wilson R.; Kahn R.A.; Plagnol V.; Wolfrum U.; Banin E.; Hardcastle A.J.; Cheetham M.E.; Sharon D.; Webster A.R.;
Am. J. Hum. Genet. 93:321-329(2013)
Cited for: VARIANT RP82 ARG-45; INTERACTION WITH ARL2; SUBCELLULAR LOCATION; TISSUE SPECIFICITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.